Список литературы

451. Rasmussen T. Health, recovery and rehabilitation after infective endocarditis. Thesis for: PhD in Health and Medical Sciences. 2015. p. 74. https://doi.org/10.13140/RG.2.2.20263.75687.

452. Rasmussen TB, Zwisler AD, Sibilitz KL, et al. A randomised clinical trial of comprehensive cardiac rehabilitation versus usual care for patients treated for infective endocarditis-the CopenHeart IE trial protocol. BMJ Open. 2012;2:1929. https://doi.org/10.1136/bmjopen-2012-001929.

453. Sanz M, Ceriello A, Buysschaert M, et al. Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology. Diabetes Res Clin Pract. 2018;137:231-41. https://doi.org/10.1016/j.diabres.2017.12.001.

454. Thornhill MH, Gibson TB, Yoon F, et al. Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures. J Am Coll Cardiol. 2022 Sep 13;80(11):1029-1041. doi: 10.1016/j.jacc.2022.06.030.

455. Wilson WR, Gewitz M, Lockhart PB, et al. Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association. Circulation. 2021 May 18;143(20):e963-e978. doi: 10.1161/CIR.0000000000000969.

456. Corra U, Piepoli MF, Carre F, et al. Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: Key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitat. Eur Heart J. 2010;31:1967-74. https://doi.org/10.1093/eurheartj/ehq236.

457. Samuelson G. Global strategy on diet, physical activity and health. Scand J Nutr. 2004;48:57. https://doi.org/10.1080/11026480410034349.

458. Hansen D, Abreu A, Ambrosetti M, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022 Feb 19;29(1):230-245. doi: 10.1093/eurjpc/zwab007.

459. Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020 Dec;54(24):1451-1462. doi: 10.1136/bjsports-2020-102955.

460. American College of Sports Medicine. Guidelines for Exercise Testing and Prescription, 11th ed.; Liguori, G., Feito, Y., Fountaine, C., Roy, B.A., Eds.; Wolters Kluwer Health: Philadelphia, PA, USA, 2021, 906 р.

461. Lockhart PB, Brennan MT, Sasser HC, et al. Bacteremia Associated With Toothbrushing and Dental Extraction. Circulation. 2008;117:3118-25. https://doi.org/10.1161/CIRCULATIONAHA.107.758524.

462. Glenny A-M, Oliver R, Roberts GJ, et al. Antibiotics for the prophylaxis of bacterial endocarditis in dentistry. Cochrane Database Syst Rev. 2013;2013:CD003813. https://doi.org/10.1002/14651858.CD003813.pub4.

463. van der Meer JTM, Michel MF, Valkenburg HA, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet. 1992;339:135-9. https://doi.org/10.1016/0140-6736(92)90207-J.

464. Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. Eur Heart J. 1995;16:1968-74. https://doi.org/10.1093/oxfordjournals.eurheartj.a060855.

465. Isaacs D. Antibiotic prophylaxis for infective endocarditis: A systematic review and metaanalysis. J Paediatr Child Health. 2017;53(9):921-2. https://doi.org/10.1111/jpc.13684.

466. Cahill TJ, Harrison JL, Jewell P, et al. Antibiotic prophylaxis for infective endocarditis: A systematic review and meta-Analysis. Heart. 2017;103(12):937-44. https://doi.org/10.1136/heartjnl-2015-309102.

467. Brignardello-Petersen R. Antibiotic prophylaxis probably reduces the risk of developing bacteremia in patients at risk of developing infective endocarditis who are undergoing dental extractions. J Am Dent Assoc. 2017;148:e169. https://doi.org/10.1016/j.adaj.2017.08.005.

468. Benito N. Health Care-Associated Native Valve Endocarditis: Importance of Nonnosocomial Acquisition. Ann Intern Med. 2009;150:586. https://doi.org/10.7326/0003-4819-150-9-200905050-00004.

469. Yu CHY, Minnema BJ, Gold WL. Bacterial infections complicating tongue piercing. Can J Infect Dis Med Microbiol. 2010;21:e70-e74. https://doi.org/10.1155/2010/987059.

470. Polyzos KA, Konstantelias AA, Falagas ME. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace 2015;17:767–777. https://doi.org/10.1093/europace/euv053.

471. Conen A, Stortecky S, Moreillon P, et al. A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation. EuroIntervention 2021;16:1135–1140. https://doi.org/10.4244/EIJ-D-19-00993.

472. Fernández‐Hidalgo N, Almirante B, Tornos P, et al. Contemporary Epidemiology and Prognosis of Health Care-Associated Infective Endocarditis. Clin Infect Dis. 2008;47:1287- 97. https://doi.org/10.1086/592576.

473. Selton-Suty C, Célard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey. Clin Infect Dis. 2012;54:1230-9. https://doi.org/10.1093/cid/cis199.

474. Дроздов Д.В., Макаров Л.М., Баркан В.С., и др. Регистрация электрокардиограммы покоя в 12 общепринятых отведениях взрослым и детям 2023. Методические рекомендации.  Российский кардиологический журнал. 2023;28(10):5631. doi: 10.15829/1560-4071-2023-5631.

475. Lauck SB, Lewis KB, Borregaard B, de Sousa I. “What is the right decision for me?” Integrating patient perspectives through shared decision-making for valvular heart disease therapy. Can J Cardiol 2021;37:1054–1063. https://doi.org/10.1016/j.cjca.2021.02.022.

476. Llenas-Garcia J, Guerra-Vales JM, Montes-Moreno S, et al. [Nonbacterial thrombotic endocarditis: clinicopathologic study of a necropsy series]. Rev Esp Cardiol 2007;60:493–500. https://doi.org/10.1016/S1885-5857(07)60190-X.

477. Zmaili MA, Alzubi JM, Kocyigit D, et al. A contemporary 20-year Cleveland clinic experience of nonbacterial thrombotic endocarditis: etiology, echocardiographic imaging, management, and outcomes. Am J Med 2021;134: 361–369. https://doi.org/10.1016/j.amjmed.2020.06.047.

478. González Quintela A, Candela MJ, Vidal C, et al. Non-bacterial thrombotic endocarditis in cancer patients. Acta Cardiol. 1991;46:1-9.

479. Dutta T, Karas MG, Segal AZ, Kizer JR. Yield of Transesophageal Echocardiography for Nonbacterial Thrombotic Endocarditis and Other Cardiac Sources of Embolism in Cancer Patients With Cerebral Ischemia. Am J Cardiol. 2006;97:894-8. https://doi.org/10.1016/j.amjcard.2005.09.140.

480. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384;1878-88. https://doi.org/10.1016/S0140-6736(14)60128-8.

481. Busca-Arenzana C, Robles-Marhuenda A, Ramos-Ruperto L, Alvarez-Troncoso J. Nonbacterial Thrombotic Endocarditis. In: Infective Endocarditis Edited by Peter Magnusson and Robin Razmi. IntechOpen; 2019, p. 291-4. ISBN: 978-1-78984-012-4. https://doi.org/10.5772/intechopen.84398.

482. Bell WR, Starksen NF, Tong S, Porterfield JK. Trousseau’s syndrome. Devastating coagulopathy in the absence of heparin. Am J Med. 1985;79:423-30. https://doi.org/10.1016/0002-9343(85)90028-2.

483. Mantovani F, Navazio A, Barbieri A, Boriani G. A first described case of cancer-associated non-bacterial thrombotic endocarditis in the era of direct oral anticoagulants. Thromb Res. 2017;149:45-7. https://doi.org/10.1016/j.thromres.2016.11.016.

484. Pengo V, Denas G, Zoppellaro G, et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood 2018;132: 1365–1371. https://doi.org/10.1182/blood-2018-04-848333.

485. Ferrari A, Botrugno I, Bombelli E, et al. Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. Case report. World J Surg Oncol. 2008;6:49. https://doi.org/10.1186/1477-7819-6-49.

486. Mezzani A, Hamm LF, Jones AM, et al. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol. 2013;20:442-67. https://doi.org/10.1177/2047487312460484.

487. Global recommendations on physical activity for health. Geneva: WHO. 2010. p. 58. ISBN: 9789241599979.

488. Fletcher GF, Balady GJ, Amsterdam EA, et al. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:1694-740. https://doi.org/10.1161/HC3901.095960.

489. Hansen D, Dendale P, Coninx K, et al. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology. Eur J Prev Cardiol. 2017;24:1017-31. https://doi.org/10.1177/2047487317702042.

490. Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate; a longitudinal study. Ann Med Exp Biol Fenn. 1957;35:307-15.

491. Ainsworth BE, Haskell WL, Herrmann SD, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Undefined. 2011;43:1575-81. https://doi.org/10.1249/MSS.0B013E31821ECE12.

492. Kaminsky LA, Brubaker PH, Guazzi M, et al. Assessing Physical Activity as a Core Component in Cardiac Rehabilitation: A position statement of the american association of cardiovascular and pulmonary rehabilitation. J Cardiopulm Rehabil Prev. 2016;36:217-26. https://doi.org/10.1097/HCR.0000000000000191.

493. Nicolau DP, Freeman CD, Belliveau PP, et al. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39:650- 5. https://doi.org/10.1128/AAC.39.3.650.

494. Dahl A, Rasmussen R V., Bundgaard H, et al. Enterococcus faecalis Infective Endocarditis. Circulation. 2013;127:1810-7. https://doi.org/10.1161/CIRCULATIONAHA.112.001170.

495. Olaison L, Schadewitz K. Enterococcal Endocarditis in Sweden, 1995-1999: Can Shorter Therapy with Aminoglycosides Be Used? Clin Infect Dis. 2002;34:159-66. https://doi.org/10.1086/338233.

496. Hubert S, Thuny F, Resseguier N, et al. Prediction of Symptomatic Embolism in Infective Endocarditis. J Am Coll Cardiol. 2013;62:1384-92. https://doi.org/10.1016/j.jacc.2013.07.029.

497. Nadrah K, Strle F. Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections. Chemother Res Pract. 2011;2011:619321. doi: 10.1155/2011/619321

498. Tong SYC, Lye DC, Yahav D, et al.; Australasian Society for Infectious Diseases Clinical Research Network. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial. JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103.

499. Elahi MW, Huang E, Kumar V, Ghias M, Shi D. Prosthetic Aortic Valve Endocarditis Due to Candida glabrata Successfully Treated With Intravenous Micafungin Followed by Oral Fluconazole Without Surgery: A Case Report and Literature Review. Cureus. 2025 Feb 24;17(2):e79550. doi: 10.7759/cureus.79550.

500. Yang A, Tan C, Adhikari NKJ, Daneman N, Pinto R, Haynen BKM, Cohen G, Hansen MS. Time-sensitive predictors of embolism in patients with left-sided endocarditis: Cohort study. PLoS One. 2019 Apr 25;14(4):e0215924. doi: 10.1371/journal.pone.0215924.